Ajay Ahuja

Ajay Ahuja, MD, MBA, currently serves as the Chief Medical Officer at MannKind Corporation, beginning in September 2025. Prior experience includes roles such as Development and Launch Leader at Kardigan and Head of US Medical Affairs at Idorsia Pharmaceuticals Ltd, where Ahuja built a Medical Affairs function and launched drugs in Neuroscience and Cardiovascular therapy. Previous positions include Vice President of Medical Affairs at GSK and Takeda, along with leadership roles at Pfizer, Allergan, Novartis, and Tepha Inc., all focused on strategic medical and business development. Ahuja's medical training includes an MD from Washington University School of Medicine and an MBA from Harvard Business School.